News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Foto de un adulto anciano con un libro entre sus piernas y de un niño señalando el libro
Oryzon announces journal publication of final Phase IIa ALICE results with iadademstat in The Lancet Hematology
Healthcare · Access to innovation · Rare diseases · Innovative drugs · Advanced therapies
The Phase IIa study ALICE evaluated the combination of iadademstat plus azacitidine in newly…
Partners - Oryzon Genomics
Foto de la entrega del premio Nueva Empresa de Gipuzkoa 2024 a VIVEbiotech
VIVEbiotech receives the “New Company of Gipuzkoa 2024” award from ADEGI
Corporate
The award recognizes the success of companies less than 10 years old that create wealth and…
Partners - VIVEbiotech
edificio oryzon
Oryzon to provide corporate progress updates at several events in June
Healthcare · Corporate
BIO International Convention 2024. Congreso de la European Hematology Association (EHA) 2024.…
Partners - Oryzon Genomics
Debate sobre la colaboración y la transferencia biotecnológica en investigación biomédica
Collaboration, efficient management of intellectual property and creation of spin-offs, vital for technology transfer and a thriving innovation ecosystem
Healthcare · Access to innovation
AseBio has organized, within the framework of the XVII Annual Conference of Biomedical Research…
Imagen de una estructura de adn
Key Considerations for Cell and Gene Therapy Commercialization in Non-Orphan Indications
Healthcare · Access to innovation · Drug discovery
There are two important challenges for companies aiming to develop CGTs in mainstream indications.
Oryzon_AseBio
Oryzon selected as Associated Partner in the first Important Project of Common European Interest (IPCEI) in the health sector (Med4Cure project)
Healthcare · Access to innovation · Drug discovery · Rare diseases · Innovative drugs · Personalized medicine · Financing
Commission has approved up to €1 billion of State aid by six Member States: Belgium, France,…
Partners - Oryzon Genomics
Banderas de la Unión Europea ondeando frente a un edificio
Four AseBio partners will participate in the first IPCEI in the health sector that will mobilize €1 billion in grants
Healthcare · Access to innovation · Financing
The Major Project of Common European Interest 'Med4Cure' will enable member states to support a…
Foto de una prueba de Thalassemia
BCN HEALTH publishes a study estimating the cost of thalassaemia care across the world
Healthcare · Rare diseases
BCN HEALTH desarrolló un modelo de costes aplicable a nivel mundial para la atención de la…
Partners - BCN Health
Foto de un ojo y un colirio y/o gotas
Miramoon Pharma Receives Orphan Drug Designation for MP-004
Healthcare · Access to innovation · Rare diseases · Innovative drugs
Orphan Drug Designation is a special status granted by the FDA to drugs that are intended to treat…
Partners - Miramoon Pharma